Health and Healthcare

Amgen : AMGN

All Amgen Articles

701 Articles

Chris Lange | Aug 27, 2014 at 10:25 AM EDT

Rising Short Interest in Biotech Stocks

Short sellers might be inclined to bet against biotech companies because of their volatile behavior on the charts.

Lee Jackson | Aug 18, 2014 at 9:00 AM EDT

RBC’s Top Quintile Quantitative Portfolio Stocks to Buy Now

ThinkstockMost firms we cover on Wall Street have quantitative strategies for their clients, and often they use similar formulas to…

Jon C. Ogg | Aug 1, 2014 at 10:20 AM EDT

Do Layoffs in Biotech Send the Right Message?

This week's layoff announcement by Amgen may have investors and the public starting to rethink what "being a biotech company"…

Lee Jackson | Jul 28, 2014 at 8:55 AM EDT

5 Huge Biotech Catalysts Right Around the Corner for Top Stocks

ThinkstockA brand new research report from RBC highlights more than 50 biotech event catalysts that are on the horizon. These are…

Lee Jackson | Jul 21, 2014 at 8:25 AM EDT

Deutsche Bank Raises Price Targets on Top Biotech and Health Care Stocks

New research reports from the biotech, health care and medical device teams at Deutsche Bank raise price targets on three…

Lee Jackson | Jul 16, 2014 at 10:15 AM EDT

4 Top Biotechs Expected to Beat Earnings Expectations

In a research note, Leerink analysts mentioned four specific top biotech names that may have the ability to beat current…

Lee Jackson | Jul 9, 2014 at 8:40 AM EDT

UBS Very Bullish on Biotech Stocks Ahead of Second-Quarter Earnings

In a new research report, UBS analysts are very positive on some top biotech stocks before second-quarter earnings numbers hit…

Jon C. Ogg | Jun 19, 2014 at 2:05 PM EDT

Will Celgene Trigger Other Biotech Stock Splits?

Celgene has decided to join the stock split game. Even though stock splits change nothing fundamentally, 24/7 Wall St. would…

Jon C. Ogg | Jun 11, 2014 at 6:50 AM EDT

Short Sellers Remain Vigilant Against Top Biotech Stocks

ThinkstockShort sellers have many reasons to bet against a stock, some of which are hedging or part of a larger…

Jon C. Ogg | Jun 2, 2014 at 8:55 AM EDT

Analyst Cancer and Biotech Stock Picks From ASCO

ThinkstockAs the summer starts, a large agenda is out there for investors when it comes to top biotech and specialty…

Douglas A. McIntyre | May 26, 2014 at 6:53 AM EDT

Google Top Company for Pay and Benefits

Google topped all companies in terms of best pay and benefits in a new survey by online jobs site Glassdoor.…

Jon C. Ogg | May 16, 2014 at 8:30 AM EDT

Top Biotech Stocks for Cancer Cures From Cowen

ThinkstockThe conference season is starting to get into full swing, and for the top biotech stocks, that means an appearance…

Jon C. Ogg | Apr 23, 2014 at 3:35 PM EDT

Why Investors Are Not Chasing Gilead Endlessly Higher

ThinkstockBy any stretch of normal measurement in earnings season, Gilead Sciences Inc. (NASDAQ: GILD) should have been a rocketing stock…

Jon C. Ogg | Apr 22, 2014 at 4:48 PM EDT

An Earnings Tale of Two Biotechs: Gilead vs. Amgen

ThinkstockGilead Sciences Inc. (NASDAQ: GILD) and Amgen Inc. (NASDAQ: AMGN) have both reported earnings. This is a definite difference in…

Jon C. Ogg | Apr 22, 2014 at 12:00 PM EDT

Biotech Earnings Previews: Amgen, Biogen Idec, Gilead, Celgene

ThinkstockBiotech stocks took it on the chin during the sell-off. In fact, biotech stocks may have even led the sell-off…

1 … 28 29 30 31 32 … 47

Amgen : AMGN

All Amgen Articles

Rising Short Interest in Biotech Stocks

RBC’s Top Quintile Quantitative Portfolio Stocks to Buy Now

Do Layoffs in Biotech Send the Right Message?

5 Huge Biotech Catalysts Right Around the Corner for Top Stocks

Deutsche Bank Raises Price Targets on Top Biotech and Health Care Stocks

4 Top Biotechs Expected to Beat Earnings Expectations

UBS Very Bullish on Biotech Stocks Ahead of Second-Quarter Earnings

Will Celgene Trigger Other Biotech Stock Splits?

Short Sellers Remain Vigilant Against Top Biotech Stocks

Analyst Cancer and Biotech Stock Picks From ASCO

Google Top Company for Pay and Benefits

Top Biotech Stocks for Cancer Cures From Cowen

Why Investors Are Not Chasing Gilead Endlessly Higher

An Earnings Tale of Two Biotechs: Gilead vs. Amgen

Biotech Earnings Previews: Amgen, Biogen Idec, Gilead, Celgene

How to Build $3,000 a Month in Dividend Income Before You Turn 50

What Is the Best Crypto to Buy Right Now in 2026: Bitcoin, XRP, Solana, or Hyperliquid?

You Have $1 Million. Should You Retire In Sarasota Or Naples?

The 401(k) Move For 60-Year-Olds That Saves Six Figures in Lifetime Taxes: SECURE 2.0's Hidden Roth Advantage

How to Build $3,000 a Month in Dividend Income Before You Turn 50

The 401(k) Move For 60-Year-Olds That Saves Six Figures in Lifetime Taxes: SECURE 2.0’s Hidden Roth Advantage

How to Build $3,000 a Month in Dividend Income Before You Turn 50

Amgen : AMGN

All Amgen Articles

Rising Short Interest in Biotech Stocks

RBC’s Top Quintile Quantitative Portfolio Stocks to Buy Now

Do Layoffs in Biotech Send the Right Message?

5 Huge Biotech Catalysts Right Around the Corner for Top Stocks

Deutsche Bank Raises Price Targets on Top Biotech and Health Care Stocks

4 Top Biotechs Expected to Beat Earnings Expectations

UBS Very Bullish on Biotech Stocks Ahead of Second-Quarter Earnings

Will Celgene Trigger Other Biotech Stock Splits?

Short Sellers Remain Vigilant Against Top Biotech Stocks

Analyst Cancer and Biotech Stock Picks From ASCO

Google Top Company for Pay and Benefits

Top Biotech Stocks for Cancer Cures From Cowen

Why Investors Are Not Chasing Gilead Endlessly Higher

An Earnings Tale of Two Biotechs: Gilead vs. Amgen

Biotech Earnings Previews: Amgen, Biogen Idec, Gilead, Celgene

How to Build $3,000 a Month in Dividend Income Before You Turn 50

What Is the Best Crypto to Buy Right Now in 2026: Bitcoin, XRP, Solana, or Hyperliquid?

You Have $1 Million. Should You Retire In Sarasota Or Naples?

Featured Reads

The 401(k) Move For 60-Year-Olds That Saves Six Figures in Lifetime Taxes: SECURE 2.0's Hidden Roth Advantage

How to Build $3,000 a Month in Dividend Income Before You Turn 50